Diabetic Nephropathy
Editat de Shahidul Islamen Limba Engleză Paperback – sep 2026
- Discusses challenges in pathogenesis, diagnosis, and treatment of diabetic nephropathy
- Presents oxidative stress and antioxidant defense as a target for the management of diabetic kidney disease
- Includes diagnosis, prognosis, and molecular mechanisms behind the development of diabetic nephropathy
Preț: 1139.71 lei
Preț vechi: 1199.70 lei
-5% Precomandă
Puncte Express: 1710
Preț estimativ în valută:
201.40€ • 233.67$ • 175.72£
201.40€ • 233.67$ • 175.72£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9780443314087
ISBN-10: 044331408X
Pagini: 300
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 044331408X
Pagini: 300
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Challenges in Pathogenesis, Diagnosis, and Treatment of Diabetic Nephropathy: An Update
2. Roles and Cross Talks of Macrophages in Diabetic Nephropathy
3. AMPK Allostery: A Therapeutic Target for the Management or Treatment of Diabetic Nephropathy
4. Autophagy Regulation as Therapeutic Target for Diabetic Nephropathy
5. MicroRNA and Circular RNA as New Generation Therapeutic Targets in the Management of Diabetic Nephropathy
6. Caveolin-1 in the Pathogenesis and as a Therapeutic Target for Diabetic Nephropathy
7. Exosome, a Major Extracellular Vesicle, as a Therapeutic Strategy for Diabetic Nephropathy
8. Deletion of Smad3 as a Therapeutic Target for the Prevention of Renal Fibrosis and Inflammation in Diabetic Nephropathy
9. Myokines and Mitochondrial DNA as Some Novel Therapeutic Targets for the Management of Diabetic Nephropathy
10. Activation of Nrf2 Signaling Pathway as a Therapeutic Target for the Amelioration of Diabetic Nephropathy
11. YY1 as a Novel Therapeutic Target for the Prevention of Renal Fibrosis in Diabetic Nephropathy
12. Microbubbles and Ultrasound Mediated Gene Delivery as a Novel Therapeutic Approach for the Treatment of Diabetic Nephropathy
13. Human Antigen R as a Novel Therapeutic Target for the Management of Diabetic Nephropathy
14. Farnesoid X Receptor as a Potential Therapeutic Target for the Treatment of Diabetic Kidney Disease
15. SET7, a Lysine-Specific Methyl Transferase as an Epigenetic Target for the Treatment of Diabetic Nephropathy
16. DNA Methyltransferase 1 as a Therapeutic Target for Attenuating Diabetic Nephropathy
17. Roles of Non-Coding RNA CYP4B1-PS1-001 in Regulating the Proliferation of Renal Fibrosis in Diabetic Nephropathy
18. Bioactive Pure Phytochemicals in the Management and Treatment of Diabetic Nephropathy
19. Oxidative Stress and Antioxidant Defense as a Target for the Management of Diabetic Kidney Disease
20. Roles of mTOR Inhibitors in the Management of Renal Cancer and Diabetic Kidney Disease
2. Roles and Cross Talks of Macrophages in Diabetic Nephropathy
3. AMPK Allostery: A Therapeutic Target for the Management or Treatment of Diabetic Nephropathy
4. Autophagy Regulation as Therapeutic Target for Diabetic Nephropathy
5. MicroRNA and Circular RNA as New Generation Therapeutic Targets in the Management of Diabetic Nephropathy
6. Caveolin-1 in the Pathogenesis and as a Therapeutic Target for Diabetic Nephropathy
7. Exosome, a Major Extracellular Vesicle, as a Therapeutic Strategy for Diabetic Nephropathy
8. Deletion of Smad3 as a Therapeutic Target for the Prevention of Renal Fibrosis and Inflammation in Diabetic Nephropathy
9. Myokines and Mitochondrial DNA as Some Novel Therapeutic Targets for the Management of Diabetic Nephropathy
10. Activation of Nrf2 Signaling Pathway as a Therapeutic Target for the Amelioration of Diabetic Nephropathy
11. YY1 as a Novel Therapeutic Target for the Prevention of Renal Fibrosis in Diabetic Nephropathy
12. Microbubbles and Ultrasound Mediated Gene Delivery as a Novel Therapeutic Approach for the Treatment of Diabetic Nephropathy
13. Human Antigen R as a Novel Therapeutic Target for the Management of Diabetic Nephropathy
14. Farnesoid X Receptor as a Potential Therapeutic Target for the Treatment of Diabetic Kidney Disease
15. SET7, a Lysine-Specific Methyl Transferase as an Epigenetic Target for the Treatment of Diabetic Nephropathy
16. DNA Methyltransferase 1 as a Therapeutic Target for Attenuating Diabetic Nephropathy
17. Roles of Non-Coding RNA CYP4B1-PS1-001 in Regulating the Proliferation of Renal Fibrosis in Diabetic Nephropathy
18. Bioactive Pure Phytochemicals in the Management and Treatment of Diabetic Nephropathy
19. Oxidative Stress and Antioxidant Defense as a Target for the Management of Diabetic Kidney Disease
20. Roles of mTOR Inhibitors in the Management of Renal Cancer and Diabetic Kidney Disease